Private-Label Momentum Grows With Mass Retailers’ Low-Price Programs
This article was originally published in The Tan Sheet
Executive Summary
The private-label sector, already growing as consumers react to a weak economy, received a boost when mass-market retailers Wal-Mart and Target added nonprescription drugs to low-price pharmacy programs